Revenue: The sum of all revenue fields included for a company's operating activities.
Forte Biosciences, Inc. (FBRX) Revenue data is not available for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
|
Revenue |
-- |
$-17.68M |
|
-- |
|
-- |
|
$18.38M |
|
$-18.38M |
|
$0.70M |
|
$-17.68M |
|
$-17.68M |
|
$-17.68M |
|
$-17.68M |
|
$-17.68M |
|
$-17.68M |
|
$-18.38M |
|
$-18.37M |
|
17.79M |
|
17.79M |
|
$-0.99 |
|
$-0.99 |
|
| Balance Sheet Financials | |
$95.41M |
|
$0.15M |
|
$1.68M |
|
$97.09M |
|
$12.99M |
|
-- |
|
-- |
|
$12.99M |
|
$84.10M |
|
$84.10M |
|
$84.10M |
|
12.52M |
|
| Cash Flow Statement Financials | |
$-34.42M |
|
$36.23M |
|
$69.35M |
|
$22.24M |
|
$93.41M |
|
$71.17M |
|
$4.59M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.34 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-34.53M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-21.03% |
|
-21.03% |
|
-18.21% |
|
-21.03% |
|
$6.71 |
|
$-1.94 |
|
$-1.93 |
|